KITE PHARMA INC filings

SEC filings by KITE PHARMA INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2017-10-05JPMORGAN CHASE & COKite Pharma, Inc.1,215,7902.1%EDGAR
SC 13G/A2017-09-08Capital Research Global InvestorsKite Pharma, Inc.2,213,3713.8%EDGAR
SC 13G/A2017-02-15Belldegrun ArieKite Pharma, Inc.3,305,5976.6%EDGAR
SC 13G/A2017-02-14FMR LLCKite Pharma, Inc.903,5731.8%EDGAR
SC 13G/A2017-02-14VIKING GLOBAL INVESTORS LPKite Pharma, Inc.00.0%EDGAR
SC 13G/A2017-02-13Capital Research Global InvestorsKite Pharma, Inc.6,109,77112.2%EDGAR
SC 13G/A2017-02-10VANGUARD GROUP INCKite Pharma, Inc.3,154,2586.3%EDGAR
SC 13G2017-01-30BlackRock Inc.Kite Pharma, Inc.3,369,6856.8%EDGAR
SC 13G2017-01-26JPMORGAN CHASE & COKite Pharma, Inc.--EDGAR
SC 13G2016-02-29VIKING GLOBAL INVESTORS LPKite Pharma, Inc.2,441,2325.0%EDGAR
SC 13G/A2016-02-16VIKING GLOBAL INVESTORS LPKite Pharma, Inc.2,207,2034.6%EDGAR
SC 13G/A2016-02-16Capital Research Global InvestorsKite Pharma, Inc.5,939,55312.2%EDGAR
SC 13G/A2016-02-12Belldegrun ArieKite Pharma, Inc.3,303,8696.6%EDGAR
SC 13G/A2016-02-12Alta Partners VIII, L.P.Kite Pharma, Inc.1,761,9573.7%EDGAR
SC 13G2016-02-12FMR LLCKite Pharma, Inc.3,544,8797.3%EDGAR
SC 13G2016-02-10VANGUARD GROUP INCKite Pharma, Inc.2,629,3425.4%EDGAR
SC 13G2015-10-05VIKING GLOBAL INVESTORS LPKite Pharma, Inc.2,688,7386.1%EDGAR
SC 13G2015-02-12Nussbaum RanKite Pharma, Inc.2,251,9365.1%EDGAR
SC 13G2015-02-12BONDERMAN DAVIDKite Pharma, Inc.2,408,0845.5%EDGAR
SC 13G2015-02-12Alta Partners VIII, L.P.Kite Pharma, Inc.2,926,0597.0%EDGAR